These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9664517)

  • 41. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
    Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
    Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
    Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular staging of prostate cancer.
    Wood DP
    Semin Urol; 1995 May; 13(2):96-102. PubMed ID: 7638475
    [No Abstract]   [Full Text] [Related]  

  • 45. [Detection of PSA mRNA and PSMA mRNA by RT-PCR].
    Deguchi T; Ehara H; Takahashi Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():151-5. PubMed ID: 12599562
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
    Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
    Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
    Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
    Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen.
    Heston WD
    Clin Chem; 1995 Dec; 41(12 Pt 1):1687-8. PubMed ID: 7497605
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhanced photoacoustic detection of melanoma cells using gold nanoparticles.
    McCormack DR; Bhattacharyya K; Kannan R; Katti K; Viator JA
    Lasers Surg Med; 2011 Apr; 43(4):333-8. PubMed ID: 21500228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The detection of circulating prostatic cells using RT-PCR].
    Eschwege P
    Prog Urol; 1997 Feb; 7(1):92-6. PubMed ID: 9116747
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer.
    Ablin RJ
    Br J Urol; 1993 Jun; 71(6):761-2. PubMed ID: 7688264
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells.
    Makarovskiy AN; Ackerley W; Wojcik L; Halpert GK; Stein BS; Carreiro MP; Hixson DC
    J Clin Lab Anal; 1997; 11(6):346-50. PubMed ID: 9406055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flow cytometry in carcinoma of the prostate.
    Benson MC; Ring K; Giella J
    Urol Clin North Am; 1990 Nov; 17(4):885-91. PubMed ID: 2219584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Qualitative low-level internal control for nested RT-PCR.
    Denis MG; Lustenberger P
    Biotechniques; 1995 Dec; 19(6):906-8. PubMed ID: 8747654
    [No Abstract]   [Full Text] [Related]  

  • 55. Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells.
    Henke W; Jung M; Jung K; Lein M; Schlechte H; Berndt C; Rudolph B; Schnorr D; Loening SA
    Clin Chem; 1996 Sep; 42(9):1499-500. PubMed ID: 8787717
    [No Abstract]   [Full Text] [Related]  

  • 56. Sensitivity or specificity of reverse transcriptase-polymerase chain reaction assays: the real challenge for molecular staging of prostatic carcinomas.
    Gala JL; Loric S
    Int J Cancer; 1998 Jul; 77(1):161-3. PubMed ID: 9639408
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prostatic antigen in pathologic anatomy].
    Varela Durán J
    Med Clin (Barc); 1992 Oct; 99(14):556-8. PubMed ID: 1279331
    [No Abstract]   [Full Text] [Related]  

  • 58. [Assessment of cells from solid tumors in peripheral blood].
    Thøgersen VB; Nexø E
    Ugeskr Laeger; 1996 Jul; 158(31):4418. PubMed ID: 8760002
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular detection of circulating prostate cells in cancer II: Comparison of prostate epithelial cells isolation procedures.
    Berteau P; Dumas F; Gala JL; Eschwège P; Lacour B; Philippe M; Loric S
    Clin Chem; 1998 Aug; 44(8 Pt 1):1750-3. PubMed ID: 9702968
    [No Abstract]   [Full Text] [Related]  

  • 60. New circulating tumor cell technology could advance personalized medicine in prostate cancer.
    Miller S
    Nanomedicine (Lond); 2013 May; 8(5):683-4. PubMed ID: 23656263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.